These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 11091147)

  • 21. [Perspectives for the development of vaccines and immunotherapy against cervico-uterine cancer].
    Guzmán-Rojas L; Alcocer-González JM; Madrid-Marina V
    Salud Publica Mex; 1998; 40(1):38-46. PubMed ID: 9567657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HPV vaccine.
    AIDS Patient Care STDS; 1999 Feb; 13(2):76. PubMed ID: 11362122
    [No Abstract]   [Full Text] [Related]  

  • 23. Vaccines discussed at papillomavirus conference.
    Larsen NS
    J Natl Cancer Inst; 1993 Nov; 85(21):1717-8. PubMed ID: 8105100
    [No Abstract]   [Full Text] [Related]  

  • 24. Preventive vaccines for cervical cancer.
    Wheeler CM
    Salud Publica Mex; 1997; 39(4):283-7. PubMed ID: 9337561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumour virus vaccines: hepatitis B virus and human papillomavirus.
    Stanley M
    Philos Trans R Soc Lond B Biol Sci; 2017 Oct; 372(1732):. PubMed ID: 28893935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The status of HPV16-specific T-cell reactivity in health and disease as a guide to HPV vaccine development.
    van der Burg SH; de Jong A; Welters MJ; Offringa R; Melief CJ
    Virus Res; 2002 Nov; 89(2):275-84. PubMed ID: 12445667
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overview of vaccinology with special reference to papillomavirus vaccines.
    Hilleman MR
    J Clin Virol; 2000 Oct; 19(1-2):79-90. PubMed ID: 11091151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles.
    Boxus M; Fochesato M; Miseur A; Mertens E; Dendouga N; Brendle S; Balogh KK; Christensen ND; Giannini SL
    J Virol; 2016 Jul; 90(14):6314-25. PubMed ID: 27147749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human papillomavirus vaccine development.
    Fife KH
    Australas J Dermatol; 1998 Nov; 39 Suppl 1():S8-10. PubMed ID: 9842094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospects for a vaccine against human papillomavirus.
    Hines JF; Ghim S; Schlegel R; Jenson AB
    Obstet Gynecol; 1995 Nov; 86(5):860-6. PubMed ID: 7566866
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention of carcinoma of cervix with human papillomavirus vaccine.
    Gavarasana S; Kalasapudi RS; Rao TD; Thirumala S
    Indian J Cancer; 2000; 37(2-3):57-66. PubMed ID: 11876611
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of mature dendritic cells for anti-human papillomavirus peptide-based vaccination in transplant patients.
    Mariat C; Alamartine E; Sabido O; Berthoux F
    Transplant Proc; 2002 Nov; 34(7):2836-7. PubMed ID: 12431627
    [No Abstract]   [Full Text] [Related]  

  • 33. Therapeutic vaccination for the treatment of mucosotropic human papillomavirus-associated disease.
    Chu NR
    Expert Opin Biol Ther; 2003 Jun; 3(3):477-86. PubMed ID: 12783616
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Anti-papillomavirus vaccines and prevention of cervical cancer: progress and prospects].
    Hantz S; Alain S; Denis F
    Presse Med; 2005 Jun; 34(10):745-53. PubMed ID: 16026130
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Public health paradoxes and the epidemiological impact of an HPV vaccine.
    Garnett GP; Waddell HC
    J Clin Virol; 2000 Oct; 19(1-2):101-11. PubMed ID: 11091153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Attitudes about human papillomavirus vaccine in young women.
    Kahn JA; Rosenthal SL; Hamann T; Bernstein DI
    Int J STD AIDS; 2003 May; 14(5):300-6. PubMed ID: 12803935
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A review of human papillomavirus vaccines: from basic science to clinical trials.
    Berry JM; Palefsky JM
    Front Biosci; 2003 May; 8():s333-45. PubMed ID: 12700045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An improved rearranged Human Papillomavirus Type 16 E7 DNA vaccine candidate (HPV-16 E7SH) induces an E7 wildtype-specific T cell response.
    Ohlschläger P; Pes M; Osen W; Dürst M; Schneider A; Gissmann L; Kaufmann AM
    Vaccine; 2006 Apr; 24(15):2880-93. PubMed ID: 16472545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunobiology of papillomavirus infections.
    Stanley MA
    J Reprod Immunol; 2001; 52(1-2):45-59. PubMed ID: 11600177
    [No Abstract]   [Full Text] [Related]  

  • 40. Synthesis, properties and applications of papillomavirus-like particles.
    Sapp M; Volpers C; Streeck RE
    Intervirology; 1996; 39(1-2):49-53. PubMed ID: 8957669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.